Karakteristike pacijenata sa sumnjom na COVID-19 infekciju i ishod posete u Covid-ambulanti

Miloranka Petrov Kiurski

doi:10.5937/opmed0-56495

Miloranka Petrov Kiurski

DOI: https://doi.org/10.5937/opmed0-56495

Ključne reči: simtomi Covid-19, prisustvo komorbiditeta, testiranje na Covid-19, Vakcinalni status, kovid ambulante, upućivanje u bolnicu

Sažetak

Uvod. Oboleli od COVID-19 zbrinjavani su u kovid
ambulantama domova zdravlja, što je rasteretilo sekundarni
i tercijarni nivo zdravstvene zaštite.
Cilj. Ispitati karakteristike pacijenata u pogledu simptoma,
rezultata testiranja, prisustva komorbiditeta i ishoda
nakon pregleda.
Metod. Popunjavan je Upitnik za pacijente koji su se od
23. do 29. aprila 2021. javili na pregled. Dobijeni su podaci
o polu, starosti, simptomima, komorbiditetima, vakcinalnom
statusu i ishodu posete. Podaci su statistički obrađeni u SPSS
programu.
Rezultati. Bilo je 222 ispitanika oba pola (61,7% žena),
prosečne starosti 47,9±15,2 godina. Vakcinisano je 24,8%, a
60,4% je bilo kovid pozitivno. Najčešće tegobe bile su umor,
bolovi u mišićima i zglobovima, kašalj i temperatura. Oko
polovine je imalo komorbiditete, najčešće pacijenti starije
životne dobi. Nije nađena statistički značajna razlika u rezultatu
testa na COVID -19 i vakcinalnog statusa (p=0,099), niti
u odnosu na prisustvo komorbiditeta (p=0,118). Pacijenti sa
blažim simptomima upućeni su na kućno lečenje, 26,1% na
dopunsku dijagnostiku, a 10,4% u bolnicu. Vakcinacija nije
uticala na ishod posete (p=0,240). Na dopunsku dijagnostiku
najčešće su upućivane osobe starosti od 51 do 65 godina, a u
bolnicu stariji od 65 godina (p=0,004) i pacijenti sa komorbiditetom
(p=0,003).
Zaključak. Nije nađena značajna razlika u pozitivnom
rezultatu testa na COVID-19 u odnosu na vakcinaciju
i prisustvo komorbiditeta. Samo 10% pacijenata je upućeno
u bolnicu, najčešće stariji od 65 godina i pacijenti sa komorbiditetom.

Reference

Khan AH, Tirth V, Fawzy M, Mahmoud AED, Khan NA, Ahmed S, et al. COVID-19 transmission, vulnerability, persistence and nanotherapy: a review. Environ Chem Lett 2021;19(4):2773–87.

Anand U, Cabreros C, Mal J, Ballesteros F, Sillanpää M, Tripathi V, et al. Novel coronavirus disease 2019 (COVID-19) pandemic: From transmission to control with an interdisciplinary vision. Environ Res 2021;197:111126.

Rahman S, Villagomez Montero MT, Rowe K, Kirton R, Kunik Jr F. Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: a review of current evidence. Expert Rev Clin Pharmacol 2021;14(5):601–21.

Protokol za lečenje pacijenata sa COVID-19 [homepage on the Internet]. [cited 2025 Jan 21]. Available from: https://www.lks.org.rs/images/Documents/Obavestenja/Protokol%20za%20le%C4%8Denje%20pacijenata%20sa%20%20COVID%2019%20%D0%B0%D0%BF%D1%80%D0%B8%D0%BB%2021.pdf

Yau JWK, Lee MYK, Lim EQY, Tan JYJ, Tan KBJC, Chua RSB. Genesis, evolution and effectiveness of Singapore’s national sorting logic and home recovery policies in handling the COVID-19 Delta and Omicron waves. Lancet Reg Health West Pac 2023;35:100719.

Petrov Kiurski MĐ, Živanović SR. Clinical characteristics and diagnosis of the COVID-19 in patients in COVID outpatient clinics. Opšta Med 2022;28(1–2):14–26.

Vaughan L, Veruttipong D, Shaw JG, Levy N, Edwards L, Winget M. Relationship of socio-demographics, comorbidities, symptoms and healthcare access with early COVID-19 presentation and disease severity. BMC Infect Dis 2021;21(1):40.

Pandey R, Rai D, Tahir MW, Wahab A, Bandyopadhyay D, Lesho E, et al. Prevalence of comorbidities and symptoms stratified by severity of illness amongst adult patients with COVID-19: a systematic review. Arch Med Sci Atheroscler Dis 2022;7:e5–e23.

Htun YM, Win TT, Aung A, Latt TZ, Phyo YN, Tun TM, et al. Initial presenting symptoms, comorbidities and severity of COVID-19 patients during the second wave of epidemic in Myanmar. Trop Med Health 2021;49(1):62.

Ejaz H, Alsrhani A, Zafar A, Javed H, Junaid K, Abdalla AE, et al. COVID-19 and comorbidities: Deleterious impact on infected patients. J Infect Public Health 2020;13(12):1833–9.

Yang X, Shi F, Zhang J, Gao H, Chen S, Olatosi B, et al. Vaccination status and disease severity of COVID-19 in different phases of the pandemic. Hum Vaccin Immunother 2024;20(1):2353491.

Malik YS, Kumar N, Sircar S, Kaushik R, Bhat S, Dhama K, et al. Coronavirus Disease Pandemic (COVID-19): Challenges and a Global Perspective. Pathogens 2020;9(7):519.

Li H, Zhu X, Yu R, Qian X, Huang Y, Chen X, et al. The effects of vaccination on the disease severity and factors for viral clearance and hospitalization in Omicron-infected patients: A retrospective observational cohort study from recent regional outbreaks in China. Front Cell Infect Microbiol 2022;12:988694.